申请人:Merck Patent GmbH
公开号:US20150018343A1
公开(公告)日:2015-01-15
The present invention provides compounds of Formula (I) as M1 receptor positive allosteric modulators for the treatment of diseases mediated by the muscarinic M1 mediator.
本发明提供了一种化合物,其化学式为(I),作为M1受体正向变构调节剂,用于治疗由胆碱能M1介质介导的疾病。